- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.86 Å
- Oligo State
- homo-tetramer
- Ligands
- 8 x YB: YTTERBIUM (III) ION(Non-functional Binders)(Non-covalent)
- 4 x Y0B: 2-methoxy-6-{[(1-propyl-1H-benzimidazol-2-yl)amino]methyl}phenol
Y0B.3: 18 residues within 4Å:- Chain A: S.121, D.122, G.125, T.129, F.171, V.174, M.175, W.178, Y.297, C.302, C.303, I.304, G.458, V.460, S.461, A.462, F.466, L.478
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:W.178
- Hydrogen bonds: A:S.121, A:W.178
- Water bridges: A:S.121
- pi-Stacking: A:F.171, A:F.171
Y0B.8: 18 residues within 4Å:- Chain B: S.121, D.122, G.125, T.129, F.171, V.174, M.175, W.178, Y.297, C.302, C.303, I.304, G.458, V.460, S.461, A.462, F.466, L.478
6 PLIP interactions:6 interactions with chain B- Hydrophobic interactions: B:W.178
- Hydrogen bonds: B:S.121, B:W.178
- Water bridges: B:S.121
- pi-Stacking: B:F.171, B:F.171
Y0B.13: 18 residues within 4Å:- Chain C: S.121, D.122, G.125, T.129, F.171, V.174, M.175, W.178, Y.297, C.302, C.303, I.304, G.458, V.460, S.461, A.462, F.466, L.478
6 PLIP interactions:6 interactions with chain C- Hydrophobic interactions: C:W.178
- Hydrogen bonds: C:S.121, C:W.178
- Water bridges: C:S.121
- pi-Stacking: C:F.171, C:F.171
Y0B.18: 18 residues within 4Å:- Chain D: S.121, D.122, G.125, T.129, F.171, V.174, M.175, W.178, Y.297, C.302, C.303, I.304, G.458, V.460, S.461, A.462, F.466, L.478
6 PLIP interactions:6 interactions with chain D- Hydrophobic interactions: D:W.178
- Hydrogen bonds: D:S.121, D:W.178
- Water bridges: D:S.121
- pi-Stacking: D:F.171, D:F.171
- 4 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)
NAD.4: 34 residues within 4Å:- Chain A: I.166, I.167, P.168, W.169, N.170, K.193, P.194, A.195, E.196, Q.197, Y.225, G.226, P.227, G.230, A.231, S.234, F.244, T.245, G.246, S.247, T.248, V.250, L.253, I.254, E.269, L.270, G.271, C.303, E.349, Q.350, K.353, E.400, F.402
- Ligands: YB.2
17 PLIP interactions:17 interactions with chain A- Hydrophobic interactions: A:P.168, A:F.402, A:F.402
- Hydrogen bonds: A:I.167, A:W.169, A:N.170, A:K.193, A:E.196, A:Q.197, A:G.246, A:S.247, A:S.247, A:E.269, A:C.303, A:Q.350, A:K.353, A:E.400
NAD.9: 34 residues within 4Å:- Chain B: I.166, I.167, P.168, W.169, N.170, K.193, P.194, A.195, E.196, Q.197, Y.225, G.226, P.227, G.230, A.231, S.234, F.244, T.245, G.246, S.247, T.248, V.250, L.253, I.254, E.269, L.270, G.271, C.303, E.349, Q.350, K.353, E.400, F.402
- Ligands: YB.7
17 PLIP interactions:17 interactions with chain B- Hydrophobic interactions: B:P.168, B:F.402, B:F.402
- Hydrogen bonds: B:I.167, B:W.169, B:N.170, B:K.193, B:E.196, B:Q.197, B:G.246, B:S.247, B:S.247, B:E.269, B:C.303, B:Q.350, B:K.353, B:E.400
NAD.14: 34 residues within 4Å:- Chain C: I.166, I.167, P.168, W.169, N.170, K.193, P.194, A.195, E.196, Q.197, Y.225, G.226, P.227, G.230, A.231, S.234, F.244, T.245, G.246, S.247, T.248, V.250, L.253, I.254, E.269, L.270, G.271, C.303, E.349, Q.350, K.353, E.400, F.402
- Ligands: YB.12
16 PLIP interactions:16 interactions with chain C- Hydrophobic interactions: C:P.168, C:F.402, C:F.402
- Hydrogen bonds: C:I.167, C:W.169, C:N.170, C:K.193, C:E.196, C:Q.197, C:G.246, C:S.247, C:S.247, C:E.269, C:C.303, C:Q.350, C:K.353
NAD.19: 34 residues within 4Å:- Chain D: I.166, I.167, P.168, W.169, N.170, K.193, P.194, A.195, E.196, Q.197, Y.225, G.226, P.227, G.230, A.231, S.234, F.244, T.245, G.246, S.247, T.248, V.250, L.253, I.254, E.269, L.270, G.271, C.303, E.349, Q.350, K.353, E.400, F.402
- Ligands: YB.17
16 PLIP interactions:16 interactions with chain D- Hydrophobic interactions: D:P.168, D:F.402, D:F.402
- Hydrogen bonds: D:I.167, D:W.169, D:N.170, D:K.193, D:E.196, D:Q.197, D:G.246, D:S.247, D:S.247, D:E.269, D:C.303, D:Q.350, D:K.353
- 4 x CL: CHLORIDE ION(Non-functional Binders)
CL.5: 6 residues within 4Å:- Chain A: R.143, T.155, H.157, V.489
- Chain B: P.465, Y.481
Ligand excluded by PLIPCL.10: 6 residues within 4Å:- Chain A: P.465, Y.481
- Chain B: R.143, T.155, H.157, V.489
Ligand excluded by PLIPCL.15: 6 residues within 4Å:- Chain C: R.143, T.155, H.157, V.489
- Chain D: P.465, Y.481
Ligand excluded by PLIPCL.20: 6 residues within 4Å:- Chain C: P.465, Y.481
- Chain D: R.143, T.155, H.157, V.489
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Takahashi, C. et al., Development of substituted benzimidazoles as inhibitors of human aldehyde dehydrogenase 1A isoenzymes. Chem.Biol.Interact. (2024)
- Release Date
- 2024-05-01
- Peptides
- Aldehyde dehydrogenase 1A1: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.86 Å
- Oligo State
- homo-tetramer
- Ligands
- 8 x YB: YTTERBIUM (III) ION(Non-functional Binders)(Non-covalent)
- 4 x Y0B: 2-methoxy-6-{[(1-propyl-1H-benzimidazol-2-yl)amino]methyl}phenol
- 4 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)
- 4 x CL: CHLORIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Takahashi, C. et al., Development of substituted benzimidazoles as inhibitors of human aldehyde dehydrogenase 1A isoenzymes. Chem.Biol.Interact. (2024)
- Release Date
- 2024-05-01
- Peptides
- Aldehyde dehydrogenase 1A1: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A